Author:
Leandro Maria J.,Becerra-Fernandez Elena
Reference76 articles.
1. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes;Edwards;Rheumatology (Oxford),2001
2. Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;New England Journal of Medicine,2004
3. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results from a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial;Emery;Arthritis and Rheumatism,2006
4. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis and Rheumatism,2006
5. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs;Popa;Rheumatology (Oxford),2007
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献